GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Launxp Biomedical Co 6876.TWO · TWD

N/A · Taipei Exchange · 🇹🇼 Taiwan

Compare

14.00

+11.11%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2024

Revenue

TWD 2.5m

FY2020FY2024

Net income

−TWD 82.6m

FY2020FY2024

Free cash flow

−TWD 77.0m

FY2020FY2024

Shareholders' equity

TWD 108.9m

FY2020FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020
RevenueTWD 2.5mTWD 11,000——TWD 800,000
Research and developmentTWD 37.6mTWD 43.7mTWD 19.7mTWD 15.1mTWD 16.5m
Operating income−TWD 82.3m−TWD 81.0m−TWD 43.6m−TWD 34.8m−TWD 28.8m
Net income−TWD 82.6m−TWD 80.9m−TWD 43.6m−TWD 34.7m−TWD 28.8m
Diluted earnings per share-2.55-1.77-0.95-0.76-0.89

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020
Total assetsTWD 123.9mTWD 206.5mTWD 32.4mTWD 73.9mTWD 66.8m
Cash and short-term investments————TWD 58.9m
Total liabilitiesTWD 15.0mTWD 23.2mTWD 10.2mTWD 8.6mTWD 9.5m
Debt————TWD 7.9m
Shareholders' equityTWD 108.9mTWD 183.3mTWD 22.2mTWD 65.2mTWD 57.3m
Shares outstanding32m46m46m46m32m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020
Cash from operations−TWD 76.7m−TWD 59.1m−TWD 44.2m−TWD 29.0m−TWD 26.8m
Capital spending−TWD 316,000−TWD 3.3m−TWD 804,000−TWD 4.2m—
Free cash flow−TWD 77.0m−TWD 62.5m−TWD 45.0m−TWD 33.2m−TWD 26.8m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022
Revenue——TWD 2.5mTWD 11,000———
Operating income−TWD 53.7m−TWD 44.1m−TWD 38.2m−TWD 52.1m−TWD 28.9m−TWD 26.0m−TWD 17.6m
Net income−TWD 53.3m−TWD 44.6m−TWD 38.0m−TWD 52.2m−TWD 28.8m−TWD 26.1m−TWD 17.6m
Diluted earnings per share-1.63-1.38-1.18-3.50-0.89-0.81-0.55
Total assetsTWD 568.2mTWD 123.9mTWD 161.9mTWD 206.5mTWD 97.7mTWD 32.4mTWD 80.6m
Cash and short-term investments———TWD 179.7mTWD 67.0mTWD 15.2mTWD 68.2m
DebtTWD 11.9m——TWD 1.7mTWD 2.2mTWD 2.6mTWD 3.1m
Shareholders' equityTWD 285.4mTWD 108.9mTWD 147.9mTWD 183.3mTWD 89.8mTWD 22.2mTWD 73.9m

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021
Operating margin—-3303.1%-734381.8%——
Net margin—-3325.1%-735900.0%——
Return on equity—-75.9%-44.2%-196.3%-53.3%
Return on assets—-66.7%-39.2%-134.4%-47.0%
Free cash flow yield—-16.6%———
Revenue growth—22481.8%———
Earnings growth—2.0%85.6%25.5%—
Current ratio—7.53x8.63x3.20x12.42x
Equity ratio—87.9%88.8%68.5%88.3%
Interest coverage—-1953.55x-483.72x-222.65x-580.47x
R&D as a share of sales—1515.6%397054.5%——
Buybacks as a share of market value-41.3%————

Growth per year

Compound annual rate

3 years5 years10 years
Operating income33.2%——
Net income33.5%——

Valuation history

At each fiscal year end

FY2024
Price to earnings-8.3
Price to sales276.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.